Emergent BioSolutions Inc. (EBS)
NYSE · Healthcare
Emergent BioSolutions Inc. Cash Flow 2009–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||
| Operating Cash Flow | 170.6M | 58.7M | -206.3M | -34.1M | 320.2M | 536.9M | 188.0M | 41.8M | 208.1M | 54.6M | 42.5M | 112.3M | 97.0M | 39.6M | 12.2M | 98.0M | 29.9M |
| Depreciation & Amort. | 95.8M | 108.8M | 125.1M | 143.3M | 123.8M | 50.1M | 49.5M | 36.3M | 32.2M | 28.0M | 23.7M | 22.3M | 17.0M | 11.2M | 9.4M | 6.0M | 5.0M |
| Investing Activities | |||||||||||||||||
| Capital Expenditure | 13.8M | 22.9M | 51.6M | 115.8M | 224.1M | 141.9M | 86.9M | 72.1M | 54.8M | 76.2M | 44.8M | 30.7M | 42.0M | 53.8M | 54.0M | 22.1M | 33.3M |
| Free Cash Flow | 156.8M | 35.8M | -257.9M | -149.9M | 96.1M | 395.0M | 101.1M | -30.3M | 153.3M | -21.6M | -2.3M | 81.6M | 54.9M | -14.2M | -41.8M | 75.9M | -3.4M |
| Financing Activities | |||||||||||||||||
| Dividends Paid | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock Buybacks | 24.9M | 0 | 0 | 82.1M | 106.0M | 0 | 0 | 100,000 | 33.1M | 0 | 100,000 | 200,000 | 213,000 | 5.9M | 0 | 0 | — |
Emergent BioSolutions Inc. Cash Flow — FAQ
Emergent BioSolutions Inc. (EBS) cash flow over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see EBS's cash flow history?
The chart and table above show Emergent BioSolutions Inc.'s cash flow by year and by quarter, including the growth rate.